查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1654683

全球雙能量 X光吸收儀市場 - 2025 至 2033 年

Global Dual Energy X-Ray Absorptiometry Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 157 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球雙能量 X光吸收法 (DEXA) 市場規模達到 2.529 億美元，預計到 2033 年將達到 3.875 億美元，在 2025-2033 年預測期內的複合年成長率為 4.9%。

雙能量 X光吸收儀 (DEXA) 是一種非侵入性醫學影像技術，主要用於評估骨礦物質密度 (BMD) 和身體組成。它的工作原理是測量兩種不同能量水平的X光穿過人體時的吸收情況。此方法可以根據骨組織和軟組織（如肌肉和脂肪）吸收 X 光的方式精確區分它們。該系統使用兩束不同能量的X光來掃描身體。兩種能量水平之間的吸收差異可以準確測量骨密度和軟組織成分。

雙能量X光吸收儀 (DEXA) 的市場需求受到醫療保健領域的各種全球趨勢和需求的影響，特別是在骨骼健康、身體組成分析和骨質疏鬆症管理領域。例如，根據骨骼健康與骨質疏鬆基金會的數據，在美國，約有 1,000 萬人患有骨質疏鬆症，估計有 4,400 萬人患有低骨密度（骨質減少症），隨著人口老化，這一數字預計還會增加。骨質疏鬆症是老年人骨折的主要原因之一。隨著全球人口老化，對 DEXA 掃描進行骨質疏鬆症篩檢的需求顯著增加。

市場動態：

促進因素與約束因素

骨質疏鬆症和骨骼疾病盛行率上升

骨質疏鬆症和骨骼疾病盛行率的上升極大地推動了雙能量X光吸收儀（DEXA）市場的成長，預計將在預測期內推動市場的發展。骨質疏鬆症的特徵是骨礦物質密度（BMD）降低，會導致骨骼變脆弱，增加骨折風險。它在老年族群中尤其常見，尤其是停經後婦女。

例如，根據國際骨質疏鬆基金會（IOF）的數據，50歲以上的女性中大約有三分之一、男性中大約有五分之一的人在其一生中會經歷骨質疏鬆性骨折。此外，根據骨骼健康與骨質疏鬆基金會的數據，在美國，有近1,000萬人患有骨質疏鬆症，另有4,400萬人因骨密度低而面臨風險。這種廣泛的流行凸顯了早期檢測和定期篩檢的必要性，從而增加了對 DEXA 的需求。

隨著全球人口老化，骨骼健康篩檢的需求不斷增加。根據世界衛生組織的數據，到 2050 年，60 歲及以上人口的數量預計將增加到 20 億以上，其中許多人面臨骨質疏鬆症的風險。老年人更容易出現骨質減少或骨質疏鬆等骨骼健康問題，從而推動對 DEXA 掃描進行早期診斷和監測的需求。

DEXA 設備成本高

DEXA 設備的高成本是雙能量 X光吸收儀 (DEXA) 市場成長的重大障礙。 DEXA 機器的價格通常在 20,000 美元到 100,000 美元以上之間，具體取決於型號、功能和品牌。由於前期投資龐大，小型醫療機構、鄉村診所和低收入地區的醫院難以負擔此類設備。小型診所和初級保健機構可能會發現，投資 DEXA 機器在財務上不可行，特別是在醫療資金有限或骨密度篩檢尚未普及的地區。

除了最初的購買價格外，營運成本（例如電力、員工培訓和定期維護）也增加了負擔。維護 DEXA 機器需要熟練的人員、專門的校準和定期維修，這進一步增加了醫療保健提供者的營運費用。例如，中低收入國家 (LMIC) 的醫療保健中心可能難以滿足維護要求，從而導致 DEXA 設備利用不足或故障。

DEXA 機器的高成本也為諸如基於超音波的骨密度儀或定量電腦斷層掃描 (QCT) 等替代技術提供了優勢，這些技術成本較低且擴大用於篩檢。例如，基於超音波的設備更實惠（價格通常低於 10,000 美元）並提供無輻射的替代方案，使其成為預算有限的醫療保健提供者的有吸引力的選擇。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類
  • 可移植性片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 骨質疏鬆症和骨骼疾病盛行率上升
    • 限制
      • DEXA 設備成本高昂
    • 機會
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • 新興創業公司和關鍵創新者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：雙能量 X光吸收儀 (DEXA) 市場（依產品類型）

  • 中央雙能量X光吸收儀
  • 外周雙能量X光吸收儀

第 6 章：雙能量 X光吸收儀 (DEXA) 市場，以便攜性分類

  • 獨立
  • 便攜的

第 7 章：雙能量 X光吸收儀 (DEXA) 市場（按應用）

  • 骨密度測定
  • 骨質疏鬆症
  • 骨折處理
  • 其他

第 8 章：雙能量 X光吸收儀 (DEXA) 市場（按最終用戶）

  • 醫院
  • 專科診所
  • 診斷中心
  • 其他

第 9 章：雙能量 X光吸收儀 (DEXA) 市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • GE HealthCare
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 關鍵進展
    • SWOT 分析
  • Hologic, Inc.
  • OSTEOSYS Corp.
  • DMS Group
  • Swissray International, Inc.
  • Xuzhou Pinyuan Electronic Technology Co., Ltd.
  • FUJIFILM Holdings Corporation
  • Scintica Instrumentation, Inc.
  • IDETEC MEDICAL IMAGING
  • Trivitron Healthcare

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MD7679

The global Dual Energy X-Ray Absorptiometry (DEXA) market reached US$ 252.9 million in 2024 and is expected to reach US$ 387.5 million by 2033, growing at a CAGR of 4.9% during the forecast period 2025-2033.

Dual-Energy X-Ray Absorptiometry (DEXA) is a non-invasive medical imaging technique used primarily for assessing bone mineral density (BMD) and body composition. It works by measuring the absorption of X-rays at two different energy levels as they pass through the body. This method allows for precise differentiation between bone tissue and soft tissue (such as muscle and fat) based on how they absorb X-rays. The system uses two X-ray beams with different energy levels to scan the body. The difference in absorption between the two energy levels allows for accurate measurement of bone density and soft tissue composition.

The market demand for Dual-Energy X-Ray Absorptiometry (DEXA) is shaped by various global trends and needs in healthcare, particularly in the fields of bone health, body composition analysis and osteoporosis management. For instance, according to the Bone Health & Osteoporosis Foundation, in the U.S., approximately 10 million people have osteoporosis, and an estimated 44 million people have low bone density (osteopenia), with a projected increase as the population ages. Osteoporosis is one of the leading causes of bone fractures among the elderly. As the global population ages, the demand for DEXA scans for osteoporosis screening has significantly increased.

Market Dynamics: Drivers & Restraints

Rising prevalence of osteoporosis and bone disorders

The rising prevalence of osteoporosis and bone disorders is significantly driving the growth of the Dual Energy X-Ray Absorptiometry (DEXA) market and is expected to drive the market over the forecast period. Osteoporosis, characterized by reduced bone mineral density (BMD), leads to weaker bones and an increased risk of fractures. It is especially common among elderly populations, particularly post-menopausal women.

For instance, according to the International Osteoporosis Foundation (IOF), approximately 1 in 3 women over the age of 50 years and 1 in 5 men will experience osteoporotic fractures in their lifetime. Moreover, according to the Bone Health & Osteoporosis Foundation, in the United States, nearly 10 million people suffer from osteoporosis, and an additional 44 million are at risk due to low bone density. This wide prevalence underscores the need for early detection and regular screening, which boosts the DEXA demand.

As populations age globally, the demand for bone health screening increases. By 2050, the number of people aged 60 and older is expected to rise to over 2 billion according to the World Health Organization, with many in this group at risk of osteoporosis. Elderly individuals are more likely to develop bone health issues such as osteopenia or osteoporosis, driving the demand for DEXA scans for early diagnosis and monitoring.

High cost of the DEXA devices

The high cost of DEXA devices is a significant barrier to the growth of the Dual-Energy X-Ray Absorptiometry (DEXA) market. The price of a DEXA machine typically ranges from $20,000 to over $100,000, depending on the model, features, and brand. This steep initial investment makes it difficult for smaller healthcare facilities, rural clinics, and hospitals in low-income regions to afford such equipment. Small clinics and primary care practices may find it financially unfeasible to invest in DEXA machines, especially in regions with limited healthcare funding or where bone density screening is not yet a widespread practice.

Aside from the initial purchase price, operational costs (such as electricity, staff training, and regular maintenance) add to the burden. Maintaining a DEXA machine requires skilled personnel, specialized calibration, and periodic servicing, which further increases operational expenses for healthcare providers. For instance, healthcare centers in low- and middle-income countries (LMICs) may struggle to keep up with maintenance requirements, which leads to underutilization or failure of DEXA equipment.

The high cost of DEXA machines also gives an advantage to alternative technologies such as ultrasound-based bone densitometers or quantitative computed tomography (QCT), which are less expensive and increasingly used for screening. For instance, ultrasound-based devices are more affordable (with prices often under $10,000) and offer a radiation-free alternative, making them an attractive option for healthcare providers on a budget.

Segment Analysis

The global Dual Energy X-Ray Absorptiometry (DEXA) market is segmented based on product type, portability, application, end-user and region.

Product Type:

The central dual energy x-ray absorptiometry segment is expected to dominate the Dual Energy X-Ray Absorptiometry (DEXA) market share

Central DEXA scans are considered the gold standard for bone mineral density (BMD) measurement, as they provide highly accurate and reproducible results compared to peripheral DEXA or other diagnostic methods. The spine and hip are the primary sites where bone loss occurs, and measuring BMD in these regions offers a reliable assessment of fracture risk. For instance, the International Osteoporosis Foundation (IOF) and National Osteoporosis Foundation (NOF) strongly endorse central DEXA scanning for the early detection of osteoporosis and its progression, making it the most trusted and widely used method in clinical practice.

Central DEXA is widely used in osteoporosis management, as it helps in risk stratification by measuring the bone density of high-risk areas like the spine and hip, where fractures due to osteoporosis are most common. The central segment also plays a significant role in assessing fracture risk and determining the effectiveness of osteoporosis treatments like bisphosphonates, denosumab, or teriparatide. The ability to track changes in BMD over time is critical for tailoring treatment plans.

Geographical Analysis

North America is expected to hold a significant position in the Dual Energy X-Ray Absorptiometry (DEXA) market share

Osteoporosis is a significant health concern in North America especially in the United States, particularly among the elderly population, which drives the demand for bone density screenings and diagnostic tools like DEXA. According to the National Osteoporosis Foundation (NOF), around 10 million people in the U.S. suffer from osteoporosis, and an estimated 44 million people have low bone density (osteopenia), putting them at risk for fractures. This high prevalence of bone disorders significantly contributes to the demand for DEXA scans as the gold standard for diagnosing osteoporosis and assessing fracture risk.

In North America, there is a strong focus on preventive healthcare, and the general population is becoming more aware of the risks of osteoporosis and other bone-related disorders. Organizations like the National Osteoporosis Foundation (NOF) and American Bone Health run continuous public awareness campaigns to educate people about the importance of bone density testing. These initiatives encourage individuals to undergo routine DEXA screenings, thus driving demand for DEXA devices.

North America, particularly the United States and Canada, has some of the most advanced healthcare systems globally. With a high number of hospitals, clinics and specialty centers dedicated to bone health and osteoporosis management, the region has easy access to advanced diagnostic tools like DEXA machines. The U.S. healthcare system is characterized by an extensive network of diagnostic imaging centers, many of which offer DEXA scans as part of routine check-ups, contributing to high market penetration.

Asia-Pacific is growing at the fastest pace in the Dual Energy X-Ray Absorptiometry (DEXA) market

The Asia-Pacific region is home to some of the fastest-aging populations globally. For instance, Japan, China, and India are witnessing a rapid increase in their elderly populations. According to the United Nations, by 2050, the number of people aged 60 years and older in Asia will more than double to 1.3 billion. Osteoporosis and bone health issues become more prevalent with age, making bone density testing a critical part of healthcare in this demographic. The aging population in APAC increases the demand for DEXA scans for osteoporosis detection and fracture risk assessment.

The prevalence of osteoporosis is rising rapidly in many Asia-Pacific countries due to factors such as lifestyle changes, dietary habits and sedentary living. Countries like China and India, despite being home to large populations, have relatively low awareness of osteoporosis, which is leading to an increase in undiagnosed cases. According to the National Institute of Health (NIH), China and India together account for approximately 50% of the world's osteoporotic fractures. As awareness grows about the importance of bone health, the demand for DEXA scans for early diagnosis is increasing.

Competitive Landscape

The major global players in the Dual Energy X-Ray Absorptiometry (DEXA) market include GE HealthCare, Hologic, Inc., OSTEOSYS Corp., DMS Group, Swissray International, Inc., Xuzhou Pinyuan Electronic Technology Co., Ltd., FUJIFILM Holdings Corporation, Scintica Instrumentation, Inc., IDETEC MEDICAL IMAGING, Trivitron Healthcare and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Dual Energy X-Ray Absorptiometry (DEXA) market report delivers a detailed analysis with 70 key tables, more than 62 visually impactful figures, and 157 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Portability
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Osteoporosis and Bone Disorders
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of DEXA Devices
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Central Dual Energy X-ray Absorptiometry*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Peripheral Dual Energy X-ray Absorptiometry

6. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Portability

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 6.1.2. Market Attractiveness Index, By Portability
  • 6.2. Standalone*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Portable

7. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Bone Densitometry*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Osteoporosis
  • 7.4. Fracture Management
  • 7.5. Others

8. Dual Energy X-Ray Absorptiometry (DEXA) Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Others

9. Dual Energy X-Ray Absorptiometry (DEXA) Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. GE HealthCare*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Hologic, Inc.
  • 11.3. OSTEOSYS Corp.
  • 11.4. DMS Group
  • 11.5. Swissray International, Inc.
  • 11.6. Xuzhou Pinyuan Electronic Technology Co., Ltd.
  • 11.7. FUJIFILM Holdings Corporation
  • 11.8. Scintica Instrumentation, Inc.
  • 11.9. IDETEC MEDICAL IMAGING
  • 11.10. Trivitron Healthcare

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us